Drug-eluting versus bare-metal stents: when and for whom?
Beyar
Rafael
R
Rambam Health Care Campus, Technion, Israel Institute of Technology Haifa, 8 Ha'Aliyah St., Haifa 35254, Israel. r_beyar@rambam.health.gov.il
Nikolsky
Eugenia
E
D015906:Angioplasty, Balloon, Coronary / Q000191:economics / Q000379:methods*; D002170:Canada; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000628:therapy*; D003328:Coronary Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D048909:Diabetes Complications; D054855:Drug-Eluting Stents / Q000009:adverse effects; D017048:Health Care Costs; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000191:economics / Q000627:therapeutic use; D015607:Stents / Q000009:adverse effects; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000191:economics / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine